Clinical Trial Update: Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on empagliflozin for liver fibrosis and cirrhosis in chronic hepatitis B with NAFLD; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Cirrhosis
• Liver Fibrosis
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: The University of Hong Kong | Conditions: Chronic Hepatitis b, NAFLD | Phase 4 | Status: ACTIVE_NOT_RECRUITING